drugset / Trial / NCT04623840

Combined Effect of Continuous and Interval in Addition to Tadalafil Drug on Erectile Dysfunction

NCT04623840

Unknown 60 enrolled Cairo University
RandomizedParallel-groupDouble-blindTreatment

Summary

Erectile dysfunction (ED) is the persistent inability to attain and maintain a sufficient erection to permit satisfactory sexual performance. ED, a condition closely related to cardiovascular morbidity and mortality, is frequently associated with obesity. The importance of reducing cardiovascular risk factors remains fundamental to the overall vascular good health of the man, and that includes sexual vascular health. ED shares similar modifiable risks factors with coronary artery disease (CAD). Lifestyle modification that targets CAD risk factors may also lead to improvement in ED.

Timeline

Start
2020-10-12
Primary completion
2021-02-28
Completion
2021-03-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tadalafil Small molecule 5 mg

Indications